Albert L. Siu, MD, MSPH
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-2345.
Siu A.; Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus. Ann Intern Med. 2016;165:225. doi: 10.7326/L16-0102
Download citation file:
Published: Ann Intern Med. 2016;165(3):225.
The U.S. Preventive Services Task Force recommends screening for abnormal blood glucose levels as part of cardiovascular risk assessment in asymptomatic adults aged 40 to 70 years who are overweight or obese. The Task Force focused on this population because the available evidence suggests that the benefits of screening and treatment with lifestyle interventions exceed the potential harms in this group.
Drs. Barkoudah and Weinrauch suggest that evidence may be insufficient to confidently determine whether the benefits of screening may be larger. We agree that currently available screening trials are inadequate and call for larger studies that measure morbidity in addition to mortality and that extend follow-up over longer periods.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only